Development status of hydrogen molecular medicine Jan 11, 2024

Hydrogen molecular medicine has obtained clinical certification in more than 50 tertiary hospitals across the country in China.

Since 2007, Japanese scholar Professor Shigeo Ohta was the first in the world to prove that the use of small doses of hydrogen can significantly improve cerebral ischemia-reperfusion injury in rats through antioxidants. It triggered the attention and research of hydrogen molecular medicine in the entire Eastern and Western medical circles, and it was successively discovered that hydrogen has a therapeutic effect on common human chronic diseases such as cerebral ischemia, liver ischemia, myocardial ischemia, obesity, and Parkinson's disease.

To date, nearly 2,000 papers have been published internationally on related research on hydrogen molecules from H2 Generator Inhalation Machine, including more than 400 SCI papers. From ischemia-reperfusion injury to various organs of the human body, to diabetes, arteriosclerosis, hypertension, tumors, side effects of cancer radiotherapy, Alzheimer's disease, cerebrovascular disease, Parkinson's disease, brainstem infarction, and brainstem ischemia , hepatitis B, pneumonia, pulmonary nodules, cystitis, metabolic syndrome, myopathy, lupus skin disease, rheumatoid arthritis, sports muscle injury and fatigue recovery and other experimental and clinical research on various diseases.

Currently, hydrogen molecular medicine from 600ml Hydrogen Breathing Generator is used in more than 50 top tertiary hospitals across the country.
Get clinical certification!
Shanghai Second Military Medical University: The protective and conditioning effect of hydrogen on radiation (side effects of radiotherapy and chemotherapy);
Shanghai Second Military Medical University: Effect of hydrogen on neonatal cerebral ischemic hypoxic encephalopathy;
Shanghai Changhai Hospital: Protective effect of hydrogen on deafness; Anorectal Department (colitis);
Shanghai Changzheng Hospital: The conditioning and protective effects of hydrogen on myocardial ischemia;
Xi'an Fourth Military Medical University: The protective and conditioning effects of hydrogen on ophthalmic diseases;
The Second Affiliated Hospital of Zhejiang University: The protective and conditioning effect of hydrogen on cerebral ischemia and cerebral hemorrhage;
Department of Neurology, The First Affiliated Hospital of China Medical University: Regulatory effect of hydrogen on Alzheimer’s disease;
Shenyang Military Region General Hospital: Hydrogen's protective effect on cardiovascular and cerebrovascular diseases and anesthesiology research;
Beijing Tiantan Hospital: The protective effect of hydrogen on craniocerebral injury;
Shanghai Oriental Hepatobiliary Surgery Hospital: The regulatory effect of hydrogen on liver cirrhosis;
Department of Burns and Plastic Surgery, Nanjing Military Region General Hospital: The conditioning effect of hydrogen on skin damage caused by diabetes;
Beijing Naval General Hospital: Hydrogen can prevent re-blocking during arteriostomy surgery (stent and bypass);
Beijing 301 Hospital, General Hospital of the Chinese People's Liberation Army: Hydrogen can regulate the proliferation of hemangioma;
Institute of Atherosclerosis, Taishan Medical College: Research on the impact of hydrogen on arteriosclerosis;
Heilongjiang Cancer Hospital: Effect of hydrogen water on tumors.
Currently, more than 50 well-known domestic tertiary hospitals, including Shanghai Huashan Hospital, Shanghai Xinhua Hospital, Shanghai Changzheng Hospital, and Shanghai Jiao Tong University First People's Hospital, are participating in basic research and clinical trials of hydrogen molecular medicine, confirming the biomedical effects of hydrogen molecules.
At present, many domestic medical studies have found that hydrogen from 600ml H2 Inhaler has the preventive and therapeutic effects on many diseases due to its unique characteristics of selective antioxidant, anti-inflammation, anti-apoptosis, and no side effects on the human body when used in multiple doses.

Just as Academician Zhong Nanshan said about hydrogen medicine at the 2022 World Thoracic Congress: The application prospects of hydrogen molecular medicine are broad and worth looking forward to!

click here to leave a message

Leave A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.